Rock Springs Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-172,716
Closed -$16.7M 161
2020
Q2
$16.7M Buy
172,716
+7,716
+5% +$644K 0.46% 73
2020
Q1
$7.74M Buy
165,000
+5,000
+3% +$320K 0.32% 84
2019
Q4
$11.7M Buy
+160,000
New +$9.7M 0.37% 81
2017
Q4
Sell
-40,000
Closed -$1.71M 153
2017
Q3
$1.71M Buy
+40,000
New +$1.28M 0.08% 133

Other funds holding MYOK

Rock Springs Capital Management's MYOK Position: Q3 2020 in Review

Rock Springs Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 172,716 shares — an estimated $16.7M sold.

Rock Springs Capital Management first reported a position in MYOK in Q3 2017 and held it in 4 quarters. The position peaked at $16.7M in Q2 2020. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

  • Rock Springs Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Rock Springs Capital Management sold 172,716 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $16.7M.
  • Rock Springs Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
  • Rock Springs Capital Management's MyoKardia, Inc. Common Stock position peaked at $16.7M in Q2 2020.
  • 237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on Rock Springs Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.